In patients with suspected malignant pleural mesothelioma, confocal laser endomicroscopy (CLE) holds promise as a guidance tool for use in pleural biopsies and can help distinguish pleural abnormalities from pleural fibrosis, according to study results published in CHEST. The study included … More
Main Navigation Menu
➤ Pharmaceutical Drug Injury Lawsuits
➤ Asbestos and Mesothelioma Claims
➤ Benzene Diseases and Cancers Claims
➤ GenX Water Contamination Cancer Cases
➤ Breast Implants Lymphoma Cancer Cases
➤ Free Case Evaluation by Lawyer Tom Lamb
➤ About the Law Offices of Thomas J. Lamb
➤ Frequently Asked Questions (FAQs)
➤ Medical Records Copying Cost Laws
➤ Client Resources: Legal, Medical, and More
➤ Collection of Articles by Our Law Firm
Please know that you can use our Quick Contact Form to tell us a bit about your case.
Recent Articles
Malignant pleural mesothelioma: from bedside to bench and from bench to bedside
Malignant pleural mesothelioma (MPM) is a rare but very aggressive cancer of the thin tissue layer (pleura) covering the lungs. The development of MPM is strongly linked to previous exposure to the fibrous mineral asbestos, which has been widely used until the 1980s, in particular in the building … More
Serious Side Effects For Xeljanz 10 mg Dose Leads To European Drug Safety Regulatory Action
In May 2019 there was more drug safety regulatory action, this time from Europe, regarding the serious side effects associated with Xeljanz related blood clots. We get some details from this news report, “EMA Puts Temporary Restrictions on Tofacitinib Due to PE Risk”: The European Medicines … More
When Might The FDA Ban Textured Implants In The US?
As of the May 2019 the FDA has decided not to ban textured implants in the U.S. due to the lack of a strong causal relationship between this particular type of implant and Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). In contrast, Canada has the sales of textured implants … More
FDA Fails When It Come To Banning Textured Breast Implants
The U.S. will not be following in the footsteps of Canada and France as regards banning textured breast implants, at least as of May 2019. The New York Times provided us with an article on May 2, 2019, “F.D.A. Won’t Ban Sales of Textured Breast Implants Linked to Cancer” which informs us that … More
Novocure nets approval for its Tumor Treating Fields therapy in mesothelioma
Novocure’s tumor-treating electric field system scored a first-line FDA approval in mesothelioma, making it the first new treatment option in the indication in more than 15 years. Given as an add-on to the previously approved combination of Eli Lilly’s lung cancer drug Alimta and cisplatin … More